Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2001;54:205-209; doi:10.1136/jcp.54.3.205
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
J Clin Pathol 2001; 54:205-209
© 2001 Journal of Clinical Pathology

Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6

R P Hasserjian1, J Howard2, A Wood2, K Henry1, B Bain3

1 Department of Histopathology, Hammersmith Hospitals NHS Trust, Du Cane Road, London W12 0NN, UK
2 Department of Haematology, Hammersmith Hospitals NHS Trust
3 Department of Haematology, St Mary's Hospital NHS Trust, Praed St, London W2 1NY, UK

Correspondence to:
Dr Hasserjian r.hasserjian{at}ic.ac.uk

Aims—Classic erythroleukaemia (acute myeloid leukaemia M6, or M6 AML) is defined as an excess of myeloblasts in an erythroid predominant background. Leukaemia variants in which the primitive blast cells are demonstrably erythroid are extremely rare and poorly characterised. Variably referred to as "true erythroleukaemia" or "acute erythremic myelosis", they are often included within the M6 AML category even though they do not meet strict criteria for this type of AML.

Methods— Two cases of acute erythroid neoplasia are presented with clinical, morphological, immunophenotypic, and cytogenetic analysis.

Results—Both patients presented with profound anaemia, one in a setting of long standing myelodysplasia. Bone marrow examination revealed a predominant population of highly dysplastic erythroid cells in both cases. In one case, the liver was infiltrated by neoplastic erythroid cells. Both patients died within four months of diagnosis.

Conclusions—This report illustrates that cases of acute leukaemia occur in which the dominant neoplastic cell is a primitive erythroid cell without an accompanying increase in myeloblasts. This does not preclude the neoplastic clone originating in a multipotent haemopoietic stem cell, as suggested by cases arising in patients with myelodysplasia. Acute erythremic myelosis should be recognised as a distinct variant of M6 AML.

Key Words: erythroleukaemia • erythremic myelosis • Di Guglielmo • acute leukaemia


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Mazzella, F M, Schumacher, H R (2002). Acute erythremic myelosis (true erythroleukaemia): a variant of AML FAB-M6. J. Clin. Pathol. 55: 800-800 [Full Text]  
  • Vardiman, J. W., Harris, N. L., Brunning, R. D. (2002). The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100: 2292-2302 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs